First Vascular Access Company to Guarantee Hospitals Will See Cost Savings and Improved Overall Patient Outcomes
The company reports they are now providing hospitals a guarantee that they will be able to reduce their central-line associated bloodstream infections.
Company reports healthcare providers can benefit from significantly improved access to the clinically superior POWERWAND, shown to reduce CLABSIs and the overall cost of care.
Access Scientific, LLC Announces Discovery of the Cause of POWERWAND™ Catheters’ ZERO Bloodstream Infections in over 35,000 Catheter-Days of Published Use
3/22/18: Access Scientific reports POWERWAND midlines and extended-dwell catheters reach an unprecedented 35,000 catheter-days with zero associated bloodstream infections.